Buy Psilocybe Semilanceata Online Psilocybe Semilanceata

Psilocybe Semilanceata Dried For Sale is a species of Psilocybe. It is a hallucinogenic fungus that is commonly found in grass and moss in areas with considerable rainfall. Psilocybe semilanceata is the most well-known of the eight hallucinogenic Psilocybe species.

Psychoactive alkaloids, such as psilocybin, can create hallucinations, including visual, aural, and dramatic shifts in time and space perception. Psilocybe semilanceata intoxication was first seen in 1799 in London, England.

Psilocybe Semilanceata Dried is known as Liberty Cap in the United States and Magic Mushroom in the United Kingdom. The genus Psilocybe derives its name from the smooth and scale-free cap. Semi- translates to half, and -lanceata indicates spear-shaped; this alludes to the look of the mushroom’s spear-like shape.

Elias Magnus Fries, a Swedish mycologist, described Psilocybe Semilanceata Dried in 1838. He termed it Agaricus semilanceatus at the time, but Paul Kummer, a German mycologist, renamed it Psilocybe semilanceata in 1871.

Buy Psilocybe Semilanceata Identification and Description

• Cap: From 0.2 to 2cm in diameter; cream in color but when wet it is a yellow-brown with olive tinge; a central dimple or bump is on top and furrows that appear more pronounced with age. The cap changes color depending on moisture retention. Bell-shaped, conical cap.
• Gills: Greenish-grey turning purple-black or dark grey with spore maturity; Cystidia appear on the surface of the gill. The gills are narrow and quite crowded.
• Stem: 2 to 3mm in diameter; 4 to 10 cm in height. Slender, wavy and white or cream; long in comparison to the capsize. Fibrous, wavy and may appear blue or purple tinge at the base. A partial veil that deteriorates quickly.
• Smell: Musty; strong and earthy.
• Taste: Strong and earthy.
• Spores: Smooth and ellipsoidal.
• Spore color: Dark purple-brown.
• Edibility: Not edible due to hallucinogenic properties and side-effects. Those that eat it describe it as gritty or chalky.
• Habitat: Pasture; parkland and grasslands, including lawns, paths and roadsides. Likes cool, damp areas, found in lower sections of fields and meadows. Found growing in temperate areas in the Northern hemisphere including Europe, commonly the UK and Ireland. Sometimes seen in temperate regions of the Southern hemisphere. It does not grow on dung, but likes to grow on dung fertilized areas.
• Season: In the USA it is found in Autumn.
• Phylum: Basidiomycota; Class: Agaricomycetes; Order: Agaricales; Family: Hymenogastraceae; Genus: Psilocybe and Species: Semilanceata.

Psilocybe Semilanceata Look-alikes

The cap of Panaeolus semiovatus (Dung Rounhead) is not pointed like that of Psilocybe semilanceata. The cap of Panaeolina foenisecii (Mower’s Mushroom or Brown Mottlegill) is not pointed like that of Psilocybe semilanceata, but the color is comparable.

Conocybe apala resembles Psilocybe semilanceata solely in appearance, but it has brown-red spores rather than the brown-purple spores of Psilocybe semilanceata and is somewhat fragile.

Protostropharia semiglobata grows directly on dung, whereas Psilocybe semilanceata does not. Pholiotina rugosa is a lookalike, but it is deadly. If a purple-brown stain emerges when placed on white paper to dry, it is most likely Panaeolus semiovatus.

Psilocybe Semilanceata as a Hallucinogenic

Psilocybe semilanceata includes a cocktail of hallucinogenic chemicals, the major active element of which is psilocybin. The psychedelic experiences are equivalent to LSD whether the mushroom is consumed dry, fresh, powdered, or mixed to food.

Psilocybe Semilanceata Benefits

Psilocybin is generally known to be the hallucinogenic in Psilocybe semilanceata. Psilocybin (and other serotonin 2A agonists) – traditional psychedelics have been utilized in indigenous civilizations for ages, generally in a ceremonial context.

For Indians, Psilocybe semilanceata is a sacred fungus; historically, it is said to guide them on a religious route to the spirit realm. Despite the fact that it is prohibited in many countries, a number of research have been conducted to investigate the medical potential of this fungus.

The scientific evidence for the potential of psilocybin to treat a variety of behavioral and mental diseases, including alcohol addiction, depression, headaches, and obsessive-compulsive disorder (OCD), will be given here.

This evidence does not justify the usage of Psilocybe semilanceata, but it deserves to be noted because it was reviewed in a recent scholarly article. Psilocybin or Psilocybe semilanceata should not be self-administered for therapeutic or recreational purposes. Always seek medical attention.

OCD

In a controlled clinical setting, nine patients were given psilocybin. It was used safely; one patient experienced temporary hypertension. Several patients reported acute decreases in their core OCD symptoms, which is promising but not conclusive and may lend credence to future studies examining the effects and processes.

Cluster Headaches

Psilocybin has been reported to be useful for both the prevention and treatment of cluster headaches and migraines. The findings were based on subjective opinions from patients suffering from treatment-resistant migraines or cluster headaches who are looking into other possibilities.

Depression

In open-label trials, patients with treatment-resistant depression were given psilocybin to see if it worked. This sort of experiment provides limited conclusions about treatment efficacy; however, tolerability was regarded as good, and there were fast symptom improvements that lasted for 6 months post-treatment.

Psilocybin may be a promising treatment for resistant depression in this aspect, and future investigations should be conducted in double-blind randomized trials.

Anxiety

Cancer patients frequently experience depression and anxiety. In one study, high-doses of psilocybin were found to improve mood, attitudes, and behaviors in cancer patients with life-threatening diagnoses. These were changes noted by clinicians as well as community observers.

Smoking Cessation

Psilocybin, in combination with cognitive behavioral therapy (CBT) was provided for patients to observe the effects on smoking cessation. The results showed that psilocybin is able to promote long term smoking cessation in 60% of individuals still abstaining from smoking.

Alcohol Dependence

Following oral dose of psilocybin to ten participants with alcohol dependence, abstinence from alcohol increased and cravings reduced. The psilocybin was administered in conjunction with treatment; however, therapy alone had little effect. In this patient group, there were no notable treatment-related side effects